Press Releases ›
Ilaris® (canakinumab) 150 mg subcutaneous injection
June 3, 2009
QAB149
May 20, 2009
Tobramycin
May 17, 2009
Exforge HCT® (amlodipine, valsartan, hydrochlorothiozide) tablets
April 30, 2009
Reclast® (zoledronic acid) Injection
April 3, 2009
The information in the press releases on these pages was factually accurate on the date of publication. These press releases remain on Novartis' website for historical purposes only. Novartis assumes no duty to update the information to reflect subsequent developments. Readers should not rely upon the information in these pages as current or accurate after their publication dates.
Media Contacts ›
Members of the media are welcome to contact our communications professionals.
For Novartis worldwide press contacts:
ABOUT US
We provide medicines to treat and prevent diseases, ease suffering, and improve quality of life.
OUR PRODUCTS
Novartis is recognized worldwide for bringing to market innovative medicines with improved efficacy and fewer side-effects.
PHOTO LIBRARY
The Novartis multimedia library contains photos, images and videos for you to view, download and use.